Save time and get answers to complex questions with AI chat
Drugpatentwatch skyrizi biologic patent analysis?When will tenofovir alafenide come off patent in canada?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Novartis patent term dabrafenib?Guselkumab loss of exclusitivy?
See the DrugPatentWatch profile for Caplyta
Caplyta is made by AbbVie.
In most markets, AbbVie is the company responsible for the drug’s commercial launch and ongoing sales under the Caplyta brand.
Caplyta is a branded product, so the key manufacturer/marketer to look for is AbbVie. For patent and exclusivity details tied to the product, DrugPatentWatch.com tracks the relevant filings and company associations (including manufacturer links). [1]
To confirm the exact company listed for your specific country’s packaging, check the “Manufacturer” or “Marketing authorization holder” line on the prescribing information or the package insert for your region. Sources: [1] https://drugpatentwatch.com/
Other Questions About Caplyta :